Sign inJoin waitlistJoin the waitlist

LK

Lee Krug

Physician · New York Presbyterian Hospital

Credentials: · ·

History

New York Presbyterian Hospital
Present

Medical Oncology
Internal Medicine

Research

Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer
Journal of Clinical Oncology · 2005 · 769 citations
Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer
Journal of Clinical Oncology · 2004 · 622 citations
Non-small cell lung cancer
Review · Journal of the National Comprehensive Cancer Network · 2010 · 522 citations

MK
Mark Kris
55 papers
VM
Vincent Miller
31 papers
Christopher Azzoli
25 papers · 1 as a fellow
Valerie Rusch
23 papers
GR
Gregory Riely
20 papers · 1 as a fellow
NR
Naiyer Rizvi
18 papers
MP
Maria Pietanza
17 papers
Marjorie Zauderer
16 papers · 8 as a fellow
MG
Michelle Ginsberg
14 papers
RH
Robert Heelan
14 papers
Jyoti Patel
13 papers
Kenneth Rosenzweig
13 papers

Clinical trials

Do Your Genes Put You at a Higher Risk of Developing Mesothelioma
Principal investigator · Completed
Wake Forest University
2011–2015
Immunization With a Pentavalent Vaccine Composed of KLH-conjugates of GD2L, GD3L, Globo H, Fucosyl GM1, and N-Propionylated Polysialic Acid
Principal investigator · Completed · Phase 1
Memorial Sloan Kettering Cancer Center
2011–2015
Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity
Principal investigator · Completed · Phase 2
Memorial Sloan Kettering Cancer Center
2009–2012
Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II)
Principal investigator · Completed · Phase 1, Phase 2
CanBas Co. Ltd.
2008–2012